
What smart money is saying about Inari Medical, Inc.
1 fund in our archive has pitched Inari Medical, Inc. — most recently Baron Opportunity Fund in December 2024.
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Get an email when a fund writes about it
Fund coverage · 1 thesis
- Baron Opportunity FundDecember 2024
Inari Medical, Inc. is a promising investment due to its innovative catheter-based devices for treating venous thromboembolism and its potential for significant market growth, which attracted Stryker's acquisition offer.
Read the full thesis
Read every full thesis on Inari Medical, Inc.
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→